Mitoxantrone use in breast cancer patients with elevated bilirubin Rowan T. ChlebowskiLinda BulcavageRobert Elashoff Report Pages: 267 - 274
Antitumor activity of the antiprogestins ZK 98.299 and RU 38.486 in hormone dependent rat and mouse mammary tumors: Mechanistic studies Horst MichnaMartin R. SchneiderM. Fathy El Etreby Report Pages: 275 - 288
Endocrine effects of combined somatostatin analog and bromocriptine therapy in women with advanced breast cancer Andrea ManniAlice E. BoucherMary Bartholomew Report Pages: 289 - 298
Inhibitory effect of androgens on DMBA-induced mammary carcinoma in the rat Sophie DauvoisShengmin LiFernand Labrie Report Pages: 299 - 306
Growth inhibition of MXT mammary carcinoma by enhancing programmed cell death (apoptosis) with analogs of LH-RH and somatostatin Bela SzendeKaroly LapisAndrew V. Schally Report Pages: 307 - 314
Metachronous seeding of lymph node metastases in rats bearing the MT-100-TC mammary carcinoma: The effect of elective lymph node dissection Pamela M. WardLeonard Weiss Report Pages: 315 - 320
Influence of S-phase fraction on metastatic pattern and post-recurrence survival in a randomized mammography screening trial Thomas HatschekJohn CarstensenBo Nordenskjöld Report Pages: 321 - 327
Correlation of growth fraction by Ki-67 immunohistochemistry with histologic factors and hormone receptors in operable breast carcinoma Giampietro GaspariniSandro Dal FiorPierantonio Bevilacqua Report Pages: 329 - 336
Polypeptide composition of normal and neoplastic human breast tissues and cells analyzed by two-dimensional gel electrophoresis Terry M. MaloneyPhilip L. PaineJose Russo Report Pages: 337 - 348
Tissue ferritin concentration and prognosis in carcinoma of the breast Robert E. WeinsteinBernice H. BondDavid R. Pieper Report Pages: 349 - 353